It is a pharma private limited company based in Nashik, Maharashtra, India, established in 2020.
2020 | Nashik, Maharashtra, India | ActiveKaliberr Bioscience Private Limited, a active private limited company, was established on 23 May 2020 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2020PTC339937. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Employing 84 professional, Its leadership includes Madhu Ramadugu (Director), Madhusudan Ramratan Bhandari (Director), Sushant Madhusudan Bhandari (Director). Past directors included Phalgun Gorukanti, Pavan Kumar Gorukanti, Prakash Gangadharan. It holds ₹32.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 409 And 410, 4Th Floor Business World, Survey Number 798/2/4/5, Plot No 4/5, Govind Nagar Link Road, Nashik, Maharashtra, 422009.
U24230MH2020PTC339937
339937
23 May 2020
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kaliberr Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu Ramadugu | Director | 18 Jun 2020 | Current |
| Madhusudan Ramratan Bhandari | Director | 23 May 2020 | Current |
| Sushant Madhusudan Bhandari | Director | 23 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2022 | Past |
| Pramod Abcsdd | Director | 27 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kaliberr Bioscience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 127499.72% increase. The company also saw a substantial fall in profitability, with a 84758.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 6147.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Kaliberr Bioscience had a promoter holding of 10.00% and a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹322,988,760.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2025 | Others | ₹7.99 M | Open |
| 17 Jul 2023 | Hdfc Bank Limited | ₹14.00 Cr | Open |
| 20 Jun 2022 | Hdfc Bank Limited | ₹17.50 Cr | Open |
Explore comprehensive loan charge details -
Kaliberr Bioscience has a workforce of 84 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kaliberr Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaliberr Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 7.99 M with Charge ID 101135536 was registered on 07 Jul 2025. was completed.
A charge with Hdfc Bank Limited of Rs. 140.00 M registered on 17 Jul 2023 with Charge ID 100756511 was modified on 18 Mar 2025. was recorded as a recent event.
Kaliberr Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Kaliberr Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 175.00 M registered on 20 Jun 2022 with Charge ID 100598641 was modified on 24 Jul 2023. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 140.00 M with Charge ID 100756511 was registered on 17 Jul 2023. was documented.
The CIN of Kaliberr Bioscience Private Limited is U24230MH2020PTC339937.
Kaliberr Bioscience Private Limited is headquartered at Shop No. 409 And 410, 4Th Floor Business World, Survey Number 798/2/4/5, Plot No 4/5, Govind Nagar Link Road, Nashik, Maharashtra, 422009.
Kaliberr Bioscience Private Limited was incorporated on 23 May 2020.
The current directors of Kaliberr Bioscience Private Limited are
The primary industry of Kaliberr Bioscience Private Limited is Manufacturing.
Kaliberr Bioscience Private Limited is unlisted.
The authorized capital of Kaliberr Bioscience Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX